HBM Healthcare Investments Future Growth
Future criteria checks 5/6
HBM Healthcare Investments is forecast to grow earnings and revenue by 121.8% and 121.7% per annum respectively while EPS is expected to grow by 121.9% per annum.
Key information
121.8%
Earnings growth rate
121.9%
EPS growth rate
Capital Markets earnings growth | -14.6% |
Revenue growth rate | 121.7% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 22 Jan 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2026 | 131 | 103 | 62 | -28 | 1 |
3/31/2025 | 46 | 18 | 62 | -28 | 1 |
3/31/2024 | -42 | -72 | 2 | -28 | 1 |
12/31/2023 | -145 | -149 | -1 | -1 | N/A |
9/30/2023 | -178 | -182 | -1 | -1 | N/A |
6/30/2023 | -204 | -209 | -1 | -1 | N/A |
3/31/2023 | -142 | -146 | -1 | -1 | N/A |
12/31/2022 | -504 | -508 | -2 | -2 | N/A |
9/30/2022 | -379 | -383 | -1 | -1 | N/A |
6/30/2022 | -158 | -162 | -3 | -3 | N/A |
3/31/2022 | -74 | -78 | -10 | -10 | N/A |
12/31/2021 | 399 | 387 | -10 | -10 | N/A |
9/30/2021 | 598 | 586 | -10 | -10 | N/A |
6/30/2021 | 679 | 666 | -9 | -9 | N/A |
3/31/2021 | 769 | 756 | -3 | -3 | N/A |
12/31/2020 | 567 | 562 | -3 | -3 | N/A |
9/30/2020 | 527 | 522 | -3 | -3 | N/A |
6/30/2020 | 339 | 333 | -3 | -3 | N/A |
3/31/2020 | 189 | 183 | -4 | -4 | N/A |
12/31/2019 | 400 | 393 | -4 | -4 | N/A |
9/30/2019 | 141 | 135 | -4 | -4 | N/A |
6/30/2019 | 224 | 218 | -4 | -4 | N/A |
3/31/2019 | 216 | 209 | -3 | -3 | N/A |
12/31/2018 | 117 | 112 | -3 | -3 | N/A |
9/30/2018 | 285 | 279 | -3 | -3 | N/A |
6/30/2018 | 260 | 254 | -3 | -3 | N/A |
3/31/2018 | 121 | 116 | -3 | -3 | N/A |
12/31/2017 | 248 | 242 | -3 | -3 | N/A |
9/30/2017 | 131 | 126 | N/A | -3 | N/A |
6/30/2017 | 93 | 88 | N/A | -3 | N/A |
3/31/2017 | 142 | 137 | N/A | -2 | N/A |
12/31/2016 | -129 | -97 | N/A | 57 | N/A |
9/30/2016 | 139 | 156 | N/A | 53 | N/A |
6/30/2016 | 40 | 46 | N/A | 49 | N/A |
3/31/2016 | 27 | 24 | N/A | -5 | N/A |
12/31/2015 | 152 | 122 | N/A | -67 | N/A |
9/30/2015 | 74 | 34 | N/A | -67 | N/A |
6/30/2015 | 208 | 164 | N/A | -66 | N/A |
3/31/2015 | 304 | 258 | N/A | -16 | N/A |
12/31/2014 | 410 | 348 | N/A | -16 | N/A |
9/30/2014 | 337 | 297 | N/A | -15 | N/A |
6/30/2014 | 366 | 338 | N/A | -14 | N/A |
3/31/2014 | 371 | 354 | N/A | -14 | N/A |
12/31/2013 | 338 | 326 | N/A | -12 | N/A |
9/30/2013 | 233 | 221 | N/A | -12 | N/A |
6/30/2013 | 117 | 105 | N/A | -12 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HBMN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.2%).
Earnings vs Market: HBMN is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: HBMN is expected to become profitable in the next 3 years.
Revenue vs Market: HBMN's revenue (121.7% per year) is forecast to grow faster than the Swiss market (4.4% per year).
High Growth Revenue: HBMN's revenue (121.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if HBMN's Return on Equity is forecast to be high in 3 years time